Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
High-flow nasal oxygen therapy is commonly used in intensive care unit (ICU). Intra-hospital transfer of critical patients is frequent: 1) to perform diagnostic 2) between emergency room or medical wards and ICU. During theses transfers, oxygenation should be continued.
There is high-flow nasal oxygen therapy for transport using an external battery. This mode of operation in transport mode allows about 30-45 min of autonomy.
Intra-hospital transport under high-flow nasal oxygen therapy has been previously described on children.
The objective of this study is to evaluate the occurrence of complications during intra-hospital transports under high-flow nasal oxygen of critical patients.
High-flow nasal oxygen therapy is commonly used in intensive care unit (ICU). Intra-hospital transfer of critical patients is frequent: 1) to perform diagnostic 2) between emergency room or medical wards and ICU. During theses transfers, oxygenation should be continued.
There is high-flow nasal oxygen therapy for transport using an external battery. This mode of operation in transport mode allows about 30-45 min of autonomy.
Intra-hospital transport under high-flow nasal oxygen therapy has been previously described on children.
The objective of this study is to evaluate the occurrence of complications during intra-hospital transports under high-flow nasal oxygen of critical patients.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Evaluation of the incidence and nature of adverse events | Other | Evaluation of the incidence and nature of adverse events during intra-hospital transport of patients undergoing high-flow nasal oxygen therapy provided by intensive care units |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of severe adverse events during intra-hospital transport | To evaluate the incidence of severe adverse events during intra-hospital transport of patients treated with high-flow nasal oxygen surpervised by an ICU staff. Severe adverse event is defined by the occurrence of intubation during transport or severe hypoxemia defined as pulse oxygen saturation (SpO2 < 80%) or cardiorespiratory arrest. | Up to 28 days |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of minor adverse events during intra-hospital transport | To evaluate the incidence of minor adverse events during intra-hospital transport of patients treated with high-flow nasal oxygen surpervised by an ICU staff. Minor adverse event is defined by the occurrence of the need to increase the FiO2 or a pull-out of nasal cannulas or the use of an alternative mode of oxygenation (standard oxygen or noninvasive ventilation) or a failure of high-flow nasal oxygenation system (ie battery failure) |
Not provided
Inclusion Criteria:
Nb: Once the patient is included in the study, any intra-hospital transport under high-flow nasal oxygen therapy will be analyzed until discharge from the intensive care unit and at until D28.
Exclusion Criteria:
Not provided
Not provided
Not provided
All patients requiring intra-hospital transfer on high-flow nasal oxygen therapy will be eligible to participate in the study
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mai-Anh NAY, Dr | CHU d'Orléans | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Center of DAX | Dax | France | ||||
| CH de Martigues |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40629187 | Derived | Nay MA, Bisson A, Auvet A, Delbove A, Berrouba A, Kamel T, Desgrouas M, Boulain T. Intra-hospital transport of adult critically ill patients treated with high flow nasal cannula oxygen: a prospective observational multicenter study. Ann Intensive Care. 2025 Jul 8;15(1):93. doi: 10.1186/s13613-025-01502-7. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D016638 | Critical Illness |
| ID | Term |
|---|---|
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
| Up to 28 days |
| Martigues |
| France |
| CHU Orléans | Orléans | 45067 | France |
| CH Bretagne Atlantique vannes-Auray | Vannes | 56017 | France |